Dr. Anne Marie Valente is the co-director of the Pregnancy and Cardiovascular Disease Program at Brigham and Women’s Hospital and outpatient director of the Boston Adult Congenital Heart Disease & Pulmonary Hypertension Program. A cardiovascular medicine and adult congenital heart disease specialist, she is also an associate professor of medicine and pediatrics at Harvard Medical School. Dr. Valente is the director of the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School.She received her medical degree from University of Vermont College of Medicine. She completed a combined internal medicine/pediatrics residency, as well as pediatric cardiology, adult cardiovascular disease and cardiovascular magnetic resonance imaging fellowships at Duke University Medical Center. Dr. Valente is board certified in internal medicine, pediatrics, cardiovascular disease and pediatric cardiology.Dr. Valente’s clinical and research interests focus on adult congenital heart disease. Her current research examines heart failure complications in patients with repaired tetralogy of Fallot, a congenital heart defect. She has authored over 50 peer-reviewed publications, as well as numerous chapters and reviews about congenital heart disease imaging and the care of women with heart disease during pregnancy. She has received institutional recognition with the Lerner Research Award and the Watkins Discovery Award as well as research funding from the American Heart Association, the Children’s Miracle Network and the National Heart, Lung and Blood Institute.**The BACH program has been training clinicians in the care of adults with congenital heart disease for several decades.  For more information about the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School, please visit the program website.**The BACH program is closely integrated in the Pregnancy and Cardiovascular Disease Program.  This program involves a multi-disciplinary team dedicated to caring for women with heart disease during pregnancy. More information may be found here. Dr. Valente is highly rated in 45 conditions, according to our data. Her top areas of expertise are Tetralogy of Fallot, Congenital Heart Disease (CHD), Ebstein's Anomaly, Cardiac Ablation, and Heart Transplant.

Dr. Michael J. Landzberg is the organizing founder and director of the Boston Adult Congenital Heart and Pulmonary Hypertension Group (BACH) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Landzberg received his medical degree from HMS. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center and a fellowship in cardiovascular disease at BWH. Dr. Landzberg is board certified in internal medicine.Dr. Landzberg’s clinical interests include adult congenital heart disease and pulmonary hypertension. The author of more than 140 peer-reviewed publications, Dr. Landzberg’s research focuses on the management of congenital heart disease. Dr. Landzberg is highly rated in 41 conditions, according to our data. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is highly rated in 31 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is highly rated in 29 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Dr. Usha B. Tedrow is director of the Clinical Cardiac Electrophysiology Program at Brigham and Women’s Hospital’s (BWH) Heart Rhythm Program. A cardiovascular medicine specialist, she is also an assistant professor of medicine at Harvard Medical School (HMS).Dr. Tedrow received her medical degree from HMS. She completed an internal medicine residency and a cardiology fellowship at Massachusetts General Hospital. In addition, she completed a cardiac electrophysiology fellowship at BWH. Dr. Tedrow is board certified in internal medicine, cardiovascular disease and cardiac electrophysiology.Her clinical interests include atrial fibrillation, cardiac resynchronization and ventricular tachycardia. She is currently researching left ventricular mapping and pacing data to analyze novel ablation treatments for structural heart disease. In addition, Dr. Tedrow serves on the editorial board of Circulation: Arrhythmia and Electrophysiology, has authored over 120 peer-reviewed publications and has received research funding from the Heart Rhythm Society. Dr. Tedrow is highly rated in 25 conditions, according to our data. Her top areas of expertise are Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation.

William Sauer is a Cardiologist in Jamaica Plain, Massachusetts. Dr. Sauer is highly rated in 23 conditions, according to our data. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation.

Robert Yeh is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Yeh is highly rated in 22 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Dr. Michael N. Singh is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an instructor in pediatrics at Harvard Medical School.Dr. Singh received his medical degree from Loma Linda University School of Medicine. He completed a combined residency in medicine/pediatrics at Medical College of Ohio Hospital (now The University of Toledo Medical Center). Dr. Singh then completed a cardiology fellowship at Baystate Medical Center and fellowships in adult congenital heart disease, congenital echocardiography, Marfan syndrome/related connective tissue disorders, and pulmonary hypertension at BWH and Boston Children's Hospital. He is board certified in internal medicine, pediatrics and cardiovascular disease.Dr. Singh’s clinical interests include congenital heart disease, connective tissue disorder and Marfan syndrome. The author of 11 peer-reviewed publications, his research focuses on Marfan syndrome, adults with congenital heart disease and aortic valve dysfunction. Dr. Singh is highly rated in 120 conditions, according to our data. His top areas of expertise are Marfan Syndrome, Bicuspid Aortic Valve, Congenital Heart Disease (CHD), and Truncus Arteriosus.

Eric Secemsky is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Secemsky has been practicing medicine for over 17 years is highly rated in 19 conditions, according to our data. His top areas of expertise are Peripheral Artery Disease, Pulmonary Embolism, Atherosclerosis, Angioplasty, and Embolectomy.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is highly rated in 19 conditions, according to our data. His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Roger Laham is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Laham is highly rated in 18 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Pinak Bipin Shah is director of the Cardiac Catheterization Laboratory at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Perelman School of Medicine at the University of Pennsylvania. He completed an internal medicine residency at BWH and served as chief medical resident. He then completed fellowships in cardiovascular disease, interventional cardiology and cardiovascular clinical biometrics at BWH. He is board certified in cardiovascular disease and interventional cardiology.Dr. Shah’s clinical interests include catheterization based techniques for the treatment of complex valvular and structural heart disease as well as complex coronary intervention. Dr. Shah’s practice focuses on trans-catheter aortic valve replacement (TAVR), mitral valve interventions, PFO/ASD closure, alcohol septal ablation for hypertrophic cardiomyopathy, and high-risk percutaneous coronary intervention (PCI) cases. Dr. Shah has received research funding from the Massachusetts Department of Public Health and National Heart, Lung and Blood Institute. He has also been listed one of America’s Top Doctors by Castle Connolly. Dr. Shah is highly rated in 18 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Paul Zei is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital. He is Director of the BWH Comprehensive Atrial Fibrillation Program, with a faculty appointment at Harvard Medical School.Dr. Zei earned his medical degree and a PhD at Stanford University. He then completed Internal Medicine Internship and Residency, Cardiology Fellowship, and Cardiac Electrophysiology Fellowship training at BWH. After briefly serving on the faculty at BWH, he moved to Stanford University, where he spent eleven years as a faculty member in Cardiology and Cardiac Electrophysiology. At Stanford, Dr. Zei developed a program in complex ablation, a research program in technology innovation, and he also served as the Director of Outpatient Cardiology and ECG services. Dr. Zei then returned to Boston to re-join the faculty at BWH and Harvard Medical School.Dr. Zei’s clinical interests focus on management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation. In his role as Director of BWH’s Comprehensive Atrial Fibrillation Program, Dr. Zei brings together a multi-disciplinary approach to the management of patients with Atrial Fibrillation and leads several research initiatives to better understand and treat patients with this condition. Dr. Zei’s research interests are in understanding the basic underlying mechanisms of cardiac arrhythmias and developing new technologies to treat patients with cardiac arrhythmias. Dr. Zei is highly rated in 18 conditions, according to our data. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Dr. Neal K. Lakdawala is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an instructor in medicine at Harvard Medical School (HMS).Dr. Lakdawala received his medical degree from The University of Texas HSCSA. He completed a residency and chief residency in internal medicine at Columbia-Presbyterian Medical Center, a clinical and research fellowship in cardiovascular disease at BWH and a master’s degree in epidemiology at the Harvard School of Public Health. Dr. Lakdawala is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.His clinical expertise includes cardiomyopathy, cardiac sarcoidosis, congestive heart failure, cardiovascular genetics and heart transplantation. Dr. Lakdawala’s research and peer-reviewed publications investigate early phenotypes in genetic cardiomyopathy to identify physiology-based therapeutics for heart failure. He has received research funding from the National Institutes of Health’s Heart Failure Network. Dr. Lakdawala is highly rated in 17 conditions, according to our data. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Raymond Y. Kwong is the director of Cardiac Magnetic Resonance Imaging (MRI) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Kwong received his medical degree from University of Toronto Faculty of Medicine. He completed a residency in internal medicine at Vancouver General Hospital and a fellowship in cardiovascular disease at The George Washington University Hospital. He then completed a cardiac MRI fellowship program at the National Heart, Lung and Blood Institutes of Health. Dr. Kwong is board certified in internal medicine and cardiovascular disease.He has authored over 290 peer-reviewed publications. His clinical interests and research focus on cardiac imaging, specifically the use of cardiac MRI to assess ventricular remodeling after acute myocardial infarction. He has received multiple grants from the National Institutes of Health, American Heart Association, Canadian Institute of Health Research, and the Society for Cardiovascular Magnetic Resonance for his research. Dr. Kwong is highly rated in 17 conditions, according to our data. His top areas of expertise are Cardiomyopathy, Cardiac Amyloidosis, Hypertrophic Cardiomyopathy (HCM), Cardiac Ablation, and Heart Transplant.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is highly rated in 16 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS). He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease. Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management. Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors. Dr. Morrow is highly rated in 16 conditions, according to our data. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Garrick C. Stewart is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an instructor in medicine at Harvard Medical School. In addition, he is director of Care New England’s Advanced Heart Failure Program as part of the BWH Cardiovascular Associates at Kent Hospital in Rhode Island.Dr. Stewart received his medical degree from The Johns Hopkins University School of Medicine. He completed his internal medicine residency at BWH; he also completed fellowships in cardiovascular medicine and advanced heart failure at BWH. Dr. Stewart is board certified in advanced heart failure and transplant cardiology, internal medicine and cardiovascular disease.The author of 30 peer-reviewed publications, Dr. Stewart’s research focuses on the physiology of advanced cardiac disease, including inflammatory heart disease, cardiac sarcoidosis and ambulatory advanced heart failure. In collaboration with Dr. Lynne W. Stevenson, he designed and launched the Medical Arm of Mechanically Assisted Circulatory Support (also known as MedaMACS), a nationwide registry of medically managed, ambulatory advanced heart failure patients. Dr. Stewart is highly rated in 16 conditions, according to our data. His top areas of expertise are Sarcoidosis, Heart Failure, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Navin Kapur is a Cardiologist in Boston, Massachusetts. Dr. Kapur is highly rated in 16 conditions, according to our data. His top areas of expertise are Cardiogenic Shock, Heart Attack, Heart Failure, Heart Transplant, and Percutaneous Coronary Intervention (PCI).

Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is highly rated in 16 conditions, according to our data. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy.

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is highly rated in 15 conditions, according to our data. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Samuel Goldhaber is a Cardiologist in Boston, Massachusetts. Dr. Goldhaber is highly rated in 14 conditions, according to our data. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

Dr. Benjamin M. Scirica is a cardiovascular medicine specialist and Professor of Medicine at Harvard Medical School (HMS). He is a Senior Investigator at the Thrombolysis and Myocardial Infarction (TIMI) Study Group and leads the Accelerator for Clinical Transformation, a group that has developed a series of remote disease management programs.Dr. Scirica received his medical degree from Harvard Medical School. He completed an internal medicine residency and a cardiovascular disease fellowship at BWH. He also completed a research fellowship in cardiovascular disease with the TIMI Study Group at BWH and received a master’s degree in public health from Harvard School of Public Health. Dr. Scirica is board certified in cardiovascular disease. His is an attending physician in the Levine Cardiac Intensive Care Unit and in the Watkins Cardiovascular Clinic at BWH. His research interests center on identifying and applying novel therapeutic and care delivery strategies across the spectrum of cardiometabolic disease. Dr. Scirica is highly rated in 14 conditions, according to our data. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Cardiac Arrest, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Frederick Ruberg is a Cardiologist in Boston, Massachusetts. Dr. Ruberg is highly rated in 14 conditions, according to our data. His top areas of expertise are Primary Amyloidosis, Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is highly rated in 13 conditions, according to our data. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).